Difference between revisions of "Sertoli cell tumour"

Jump to navigation Jump to search
127 bytes added ,  10:51, 13 September 2023
Line 69: Line 69:
*Alpha-inhibin +ve (~95% of cases<ref name=pmid17721194/>).
*Alpha-inhibin +ve (~95% of cases<ref name=pmid17721194/>).
*Calretiin +ve (~55% of cases<ref name=pmid17721194/>).
*Calretiin +ve (~55% of cases<ref name=pmid17721194/>).
*Beta-catenin (nuclear +ve).<ref>{{cite journal |authors=Zhang C, Ulbright TM |title=Nuclear Localization of β-Catenin in Sertoli Cell Tumors and Other Sex Cord-Stromal Tumors of the Testis: An Immunohistochemical Study of 87 Cases |journal=Am J Surg Pathol |volume=39 |issue=10 |pages=1390–4 |date=October 2015 |pmid=26034868 |doi=10.1097/PAS.0000000000000455 |url=}}</ref>
*Beta-catenin +ve (nuclear).<ref>{{cite journal |authors=Zhang C, Ulbright TM |title=Nuclear Localization of β-Catenin in Sertoli Cell Tumors and Other Sex Cord-Stromal Tumors of the Testis: An Immunohistochemical Study of 87 Cases |journal=Am J Surg Pathol |volume=39 |issue=10 |pages=1390–4 |date=October 2015 |pmid=26034868 |doi=10.1097/PAS.0000000000000455 |url=}}</ref>
**Negative beta-catenin should make one consider other diagnoses.{{fact}}
**May be negative in malignant sertoli cell tumours.


Others:
Others:
48,466

edits

Navigation menu